Biomedical research at Oslo University Hospital

Oslo University Hospital is a merger of three former university hospitals in Oslo. Biomedical research is one of the hospital's core activities. Research at the hospital is closely interlinked with research undertaken at the University of Oslo. More than 50% of all biomedical research in Norway is published by researchers affiliated with the hospital. Research undertaken cover both basic research, translational research, and clinical research.

Oslo University Hospital has a central role in developing and supporting biomedical research within the South-Eastern Regional Health Authority. The hospital also pursues international research collaborations.

Click here to see hierarchical division and subunit overview

Summary of publications:

Publications (original articles or review articles) published in 2015 from OUS - Section for Cancer Cytogenetics

13 publications found

Agostini A, Panagopoulos I, Andersen HK, Johannesen LE, Davidson B, Tropé CG, Heim S, Micci F (2015)
HMGA2 expression pattern and TERT mutations in tumors of the vulva
Oncol Rep, 33 (6), 2675-80
DOI 10.3892/or.2015.3882, PubMed 25823555

Bassarova A, Trøen G, Spetalen S, Micci F, Tierens A, Delabie J (2015)
Lymphoplasmacytic lymphoma and marginal zone lymphoma in the bone marrow: paratrabecular involvement as an important distinguishing feature
Am J Clin Pathol, 143 (6), 797-806
DOI 10.1309/AJCP6ZODWV1CIDME, PubMed 25972321

Dale Rein I, Solberg Landsverk K, Micci F, Patzke S, Stokke T (2015)
Replication-induced DNA damage after PARP inhibition causes G2 delay, and cell line-dependent apoptosis, necrosis and multinucleation
Cell Cycle, 14 (20), 3248-60
DOI 10.1080/15384101.2015.1085137, PubMed 26312527

Olsen TK, Panagopoulos I, Meling TR, Micci F, Gorunova L, Thorsen J, Due-Tønnessen B, Scheie D, Lund-Iversen M, Krossnes B, Saxhaug C, Heim S, Brandal P (2015)
Fusion genes with ALK as recurrent partner in ependymoma-like gliomas: a new brain tumor entity?
Neuro Oncol, 17 (10), 1365-73
DOI 10.1093/neuonc/nov039, PubMed 25795305

Panagopoulos I, Bjerkehagen B, Gorunova L, Taksdal I, Heim S (2015)
Rearrangement of chromosome bands 12q14~15 causing HMGA2-SOX5 gene fusion and HMGA2 expression in extraskeletal osteochondroma
Oncol Rep, 34 (2), 577-84
DOI 10.3892/or.2015.4035, PubMed 26043835

Panagopoulos I, Gorunova L, Bjerkehagen B, Heim S (2015)
Fusion of the genes EWSR1 and PBX3 in retroperitoneal leiomyoma with t(9;22)(q33;q12)
PLoS One, 10 (4), e0124288
DOI 10.1371/journal.pone.0124288, PubMed 25875009

Panagopoulos I, Gorunova L, Bjerkehagen B, Heim S (2015)
Novel KAT6B-KANSL1 fusion gene identified by RNA sequencing in retroperitoneal leiomyoma with t(10;17)(q22;q21)
PLoS One, 10 (1), e0117010
DOI 10.1371/journal.pone.0117010, PubMed 25621995

Panagopoulos I, Gorunova L, Bjerkehagen B, Lobmaier I, Heim S (2015)
LAMTOR1-PRKCD and NUMA1-SFMBT1 fusion genes identified by RNA sequencing in aneurysmal benign fibrous histiocytoma with t(3;11)(p21;q13)
Cancer Genet, 208 (11), 545-51
DOI 10.1016/j.cancergen.2015.07.007, PubMed 26432191

Panagopoulos I, Gorunova L, Bjerkehagen B, Lobmaier I, Heim S (2015)
Fusion of the TBL1XR1 and HMGA1 genes in splenic hemangioma with t(3;6)(q26;p21)
Int J Oncol, 48 (3), 1242-50
DOI 10.3892/ijo.2015.3310, PubMed 26708416

Panagopoulos I, Gorunova L, Bjerkehagen B, Lobmaier I, Heim S (2015)
The recurrent chromosomal translocation t(12;18)(q14~15;q12~21) causes the fusion gene HMGA2-SETBP1 and HMGA2 expression in lipoma and osteochondrolipoma
Int J Oncol, 47 (3), 884-90
DOI 10.3892/ijo.2015.3099, PubMed 26202160

Panagopoulos I, Gorunova L, Kerndrup G, Spetalen S, Tierens A, Osnes LT, Andersen K, Müller LS, Hellebostad M, Zeller B, Heim S (2015)
Rare MLL-ELL fusion transcripts in childhood acute myeloid leukemia-association with young age and myeloid sarcomas?
Exp Hematol Oncol, 5, 8
DOI 10.1186/s40164-016-0037-2, PubMed 26949571

Panagopoulos I, Gorunova L, Taksdal I, Bjerkehagen B, Heim S (2015)
Recurrent 12q13-15 chromosomal aberrations, high frequency of isocitrate dehydrogenase 1 mutations, and absence of high mobility group AT-hook 2 expression in periosteal chondromas
Oncol Lett, 10 (1), 163-167
DOI 10.3892/ol.2015.3197, PubMed 26170993

Torkildsen S, Gorunova L, Beiske K, Tjønnfjord GE, Heim S, Panagopoulos I (2015)
Novel ZEB2-BCL11B Fusion Gene Identified by RNA-Sequencing in Acute Myeloid Leukemia with t(2;14)(q22;q32)
PLoS One, 10 (7), e0132736
DOI 10.1371/journal.pone.0132736, PubMed 26186352

 
Page visits: 71048